The glucose monitoring device market in Latin America is expected to reach USD 0.40 billion by 2027 from USD 0.29 billion in 2022, hiking at a CAGR of 6.96% between 2022 to 2027.
In Latin America, the market is mainly driven by increasing R & D in the field of Diabetes along with increasing awareness about disease care. But still, there is a class of people with low medical literacy rates due to which the market growth is constrained.
Blood glucose monitoring devices are used to monitor blood glucose in patients suffering from diabetes or other glucose-related diseases like glucose intolerance. Medical devices are playing an increasingly important role in diabetes. Products such as blood glucose monitors and insulin pumps have now become the cornerstone for the management of blood glucose levels.
The Latin America Glucose Monitoring devices market has witnessed major growth in the past few years and is largely driven by the increasing number of diabetic patients. The rising obese population and rapid industrialization and urbanization have also contributed to the growth of this market.
However, the high cost of diabetes care devices, the disparity in reimbursement, availability of alternative treatments, and lack of awareness inhibit the growth of this market.
This research report on the Latin American glucose monitoring device market has been segmented and sub-segmented into the following categories:
By Device Type:
By Application:
By Country:
Regionally, continuous glucose monitoring results help patients regulate their food intake, exercise, and medications. The device contains sensors for checking the glucose levels from the interstitial fluid. The sensor has a time span where it can be used in one place and then needs to be replaced. This device monitors the glucose levels over time, allowing the patients to identify low and high sugar levels that are more dangerous. Whereas for the self-monitoring devices people have to test and it monitors the level at that particular time and not before that.
Companies playing a promising role in the Latin American Glucose Monitoring Device Market profiled in this report are Roche Diagnostics, LifeScan, Bayer Health care, Abbott Diabetes care Inc., AgaMatrix Inc., Arkray Inc., Medtronic, DexCom Inc., Nova Biomedical Corporation, and Terumo Europe NV.
1. Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 New Developments
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 By Device Type
5.1.1 Continuous Wearable Devices
5.1.1.1 Sensors
5.1.1.2 Transmitters and Activators
5.1.2 Self-Monitoring Devices
5.1.2.1 Blood Glucose Meters
5.1.2.2 Blood Glucose Strips
5.1.2.3 Lancets
5.1.2.4 Haemoglobin A1C testing Kits
5.2 By Application
5.2.1 Hospitals
5.2.2 Clinics and Diagnostic Centers
5.2.3 Home Setting
5.2.4 Ambulatory Settings
6. Geographical Analysis
6.1 Introduction
6.2 Brazil
6.3 Mexico
6.4 Argentina
6.5 Rest of Latin America
7. Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8. Market Leaders' Analysis
8.1 Roche Diagnostics
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Strategic Evaluation and Operations
8.1.4 Financial analysis
8.1.5 Legal issues
8.1.6 Recent Developments
8.1.7 SWOT analysis
8.1.8 Analyst View
8.2 LifeScan
8.3 Bayer Health care
8.4 Abbott Diabetes care Inc
8.5 AgaMatrix Inc
8.6 Arkray Inc
8.7 Medtronic
8.8 DexCom Inc
8.9 Nova Biomedical Corporation
8.10 Teruma Europe NV
9. Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10. Expert Opinions
10.1 Market Outlook
10.2 Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
Related Reports
Talk to our analyst and get customised report done according to your research needs
Check if you can avail any discount. Submit your details and our team will get back to you.
Request to avail a free sample report that reflects this market and its growth.
